Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

Herbert Y. Meltzer, Lisa Arvanitis*, Deborah Bauer, Werner Rein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

319 Scopus citations

Fingerprint

Dive into the research topics of 'Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience